EcoDrugPlus

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSPLOG00000018936
Gene Symbol: FAU
4 Cross references
178 Possible Orthologues:

Fkbp Prolyl Isomerase 1a

Ensembl ID : ENSPLOG00000003810
Gene Symbol: FKBP1A
3 Cross references
264 Possible Orthologues:

Fxyd Domain Containing Ion Transport Regulator 2

Ensembl ID : ENSPLOG00000021094
Gene Symbol: FXYD2
4 Cross references
74 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSPLOG00000003022
Gene Symbol: FYN
4 Cross references
261 Possible Orthologues:

G Protein-Coupled Receptor 119

Ensembl ID : ENSPLOG00000014485
Gene Symbol: GPR119
2 Cross references
174 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSPLOG00000005296
Gene Symbol: GPR84
2 Cross references
124 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSPLOG00000012774
Gene Symbol: HCK
2 Cross references
205 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSPLOG00000001668
Gene Symbol: ITK
4 Cross references
207 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSPLOG00000007282
Gene Symbol: JAK1
2 Cross references
236 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSPLOG00000019062
Gene Symbol: JAK2
4 Cross references
265 Possible Orthologues:

Janus Kinase 3

Ensembl ID : ENSPLOG00000003939
Gene Symbol: JAK3
4 Cross references
103 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSPLOG00000003794
Gene Symbol: KIT
2 Cross references
265 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).